ArticleResearch (Washington, D.C.)2025

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

Jinhui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.